Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Ewing Sarcoma”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Early research (Phase 1)Looking for participantsNCT07297979
What this trial is testing

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Who this might be right for
Ewing Sarcoma
Amgen 50
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Early research (Phase 1)Looking for participantsNCT07172958
What this trial is testing

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Who this might be right for
RhabdomyosarcomaEwing SarcomaNeuroblastoma+1 more
Children's National Research Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT03458728
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Who this might be right for
Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenNeuroblastomaOsteosarcoma+2 more
Bayer 31
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Early research (Phase 1)Study completedNCT02076906
What this trial is testing

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

Who this might be right for
Relapsed Pediatric Solid TumorsRefractory Pediatric Solid TumorsRhabdomyosarcoma+7 more
AeRang Kim 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Early research (Phase 1)WithdrawnNCT01969942
What this trial is testing

A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
University of Louisville
Early research (Phase 1)Study completedNCT01241162
What this trial is testing

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

Who this might be right for
NeuroblastomaEwings SarcomaOsteogenic Sarcoma+2 more
University of Louisville 19
Early research (Phase 1)Looking for participantsNCT07222735
What this trial is testing

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

Who this might be right for
SarcomaChildhood OsteosarcomaChildhood Rhabdomyosarcoma+2 more
St. Jude Children's Research Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)WithdrawnNCT05042934
What this trial is testing

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaRecurrent Ewing Sarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04129151
What this trial is testing

Palbociclib + Ganitumab In Ewing Sarcoma

Who this might be right for
Ewing SarcomaEwing's Sarcoma Recurrent
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Temporarily pausedNCT04890093
What this trial is testing

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Sarcoma, EwingRhabdomyosarcoma
National Cancer Institute (NCI) 64
Early research (Phase 1)Looking for participantsNCT05210374
What this trial is testing

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Who this might be right for
Relapsed Sarcomas
Case Comprehensive Cancer Center 24
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Testing effectiveness (Phase 2)Study completedNCT01492673
What this trial is testing

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 9
Next Page